Highly sensitive and specific


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 03 2019
accepted: 10 07 2019
pubmed: 13 7 2019
medline: 28 4 2021
entrez: 13 7 2019
Statut: ppublish

Résumé

SOX11 is a valuable marker to identify biologically and clinically relevant groups of mantle cell lymphoma such as cyclin D1 negative and leukemic non-nodal mantle cell lymphoma (MCL). We aimed to establish a sensitive

Identifiants

pubmed: 31296581
pii: haematol.2019.219543
doi: 10.3324/haematol.2019.219543
pmc: PMC7049372
doi:

Substances chimiques

RNA, Messenger 0
SOX11 protein, human 0
SOXC Transcription Factors 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

754-764

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Blood. 2018 Jul 26;132(4):413-422
pubmed: 29769262
Blood. 2018 Jan 25;131(4):417-420
pubmed: 29196411
Haematologica. 2018 Jan;103(1):116-125
pubmed: 29079592
Blood. 2013 Feb 21;121(8):1394-402
pubmed: 23255553
Curr Oncol Rep. 2017 Jun;19(6):43
pubmed: 28466437
Mod Pathol. 2015 Nov;28(11):1435-47
pubmed: 26360498
Blood. 2016 Aug 25;128(8):1101-11
pubmed: 27257180
Blood. 2019 Feb 28;133(9):940-951
pubmed: 30538135
Cancer Res. 2010 Feb 15;70(4):1408-18
pubmed: 20124476
Blood. 2012 May 3;119(18):4215-23
pubmed: 22431568
Blood. 2013 Mar 21;121(12):2175-85
pubmed: 23321250
Blood. 2018 May 17;131(20):2247-2255
pubmed: 29615403
Blood. 1994 Oct 15;84(8):2726-32
pubmed: 7919385
Blood. 2008 Jan 15;111(2):800-5
pubmed: 17934069
Oncotarget. 2017 Oct 16;8(55):93392-93403
pubmed: 29212158
Hum Pathol. 2017 Mar;61:121-129
pubmed: 27993577
Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):155-159
pubmed: 28800011
Blood. 1996 May 15;87(10):4302-10
pubmed: 8639789
Blood. 2006 Aug 1;108(3):1109-10
pubmed: 16861358
Sci Rep. 2013;3:1400
pubmed: 23466598
Haematologica. 2015 Sep;100(9):e369-72
pubmed: 25887497
PLoS One. 2010 Nov 22;5(11):e14085
pubmed: 21124928
Biotech Histochem. 2017;92(6):425-435
pubmed: 28836864
Int J Hematol. 2017 Aug;106(2):212-220
pubmed: 28429312
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18250-5
pubmed: 24145436
Curr Opin Hematol. 2018 Jul;25(4):299-306
pubmed: 29738333
J Vis Exp. 2014 Mar 11;(85):
pubmed: 24637627
Haematologica. 2012 Sep;97(9):1422-30
pubmed: 22315488
Cancer Res. 2012 Oct 15;72(20):5307-16
pubmed: 22915760
Cancer Cell. 2003 Feb;3(2):185-97
pubmed: 12620412
Int J Biochem Cell Biol. 2010 Mar;42(3):381-90
pubmed: 19631281
Blood. 1996 Apr 15;87(8):3351-9
pubmed: 8605352
Leukemia. 2012 Aug;26(8):1895-8
pubmed: 22425896
Oncogene. 2015 Mar 5;34(10):1231-40
pubmed: 24681958
Biotechniques. 2005 Jul;39(1):75-85
pubmed: 16060372
Br J Haematol. 2008 Oct;143(2):248-52
pubmed: 18729857
Leukemia. 2016 Jul;30(7):1596-9
pubmed: 26710884
Nat Rev Cancer. 2007 Oct;7(10):750-62
pubmed: 17891190
Haematologica. 2009 Nov;94(11):1595-8
pubmed: 19608671
Virchows Arch. 2016 Mar;468(3):245-57
pubmed: 26298543
Blood. 2013 Mar 21;121(12):2169-70
pubmed: 23520328
Blood. 2014 Oct 2;124(14):2235-47
pubmed: 25092176
J Mol Diagn. 2012 Jan;14(1):22-9
pubmed: 22166544
J Cell Biochem. 2016 Oct;117(10):2201-8
pubmed: 27191821
Blood. 2006 Sep 15;108(6):2029-36
pubmed: 16709933
Blood. 2005 Dec 15;106(13):4315-21
pubmed: 16123218
Blood. 2017 Jul 27;130(4):501-513
pubmed: 28533307
Haematologica. 2009 Nov;94(11):1555-62
pubmed: 19880778
Blood. 2008 Jun 15;111(12):5683-90
pubmed: 18391076

Auteurs

Birgit Federmann (B)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Leonie Frauenfeld (L)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Helga Pertsch (H)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Vanessa Borgmann (V)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Julia Steinhilber (J)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Irina Bonzheim (I)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Falko Fend (F)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Leticia Quintanilla-Martinez (L)

Institute of Pathology and Neuropathology, Comprehensive Cancer Center and University Hospital Tübingen, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH